Walaiporn Kongkamsuan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Walaiporn Kongkamsuan has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Ingporn Jiamset
Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand
1 shared publication - Kulisara Nanthamongkolkul
Department of Obstetrics and Gynecology, Faculty of Medicine Prince of Songkla University Songkhla Thailand
1 shared publication - Narumon Janmunee
Division of Therapeutic Radiology and Oncology, Department of Radiology, Faculty of Medicine Prince of Songkla University Songkhla Thailand
1 shared publication - Nungrutai Saeaib
Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand
1 shared publication
Latest Publications
- 14 April 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 175 (1) , 300-309
Neutrophil‐to‐lymphocyte ratio as a prognostic marker for survival outcomes in women with cervical cancer and HIV infection
Objective: This study aimed to determine the prognostic value of neutrophil‐to‐lymphocyte ratio (NLR) in women with cervical cancer infected with HIV. Methods: This retrospective cohort study included women with cervical cancer with HIV infection who underwent primary treatment at a tertiary hospital in southern Thailand between 2005 and 2019. Overall survival (OS) and progression‐free survival (PFS) were analyzed using the Kaplan–Meier method. Univariate and multivariate Cox regression analyses were used to determine the independent factors associated with OS and PFS. Results: Among 100 patients (median follow‐up time 37.63 months), the 5‐year OS and PFS rates were 64.5% (95% confidence interval [CI]: 55.0–75.6) and 58.2% (95% CI: 48.6–69.6), respectively. In the multivariate analysis, high NLR (hazard ratio [HR]: 3.53, 95% CI: 1.58–7.91, P = 0.002) and low equivalent total dose in 2 Gy fractions at point A (HR 2.14, 95% CI: 1.02–4.49, P = 0.045) were independent predictors of worse OS, while poor performance status (HR 6.73, 95% CI: 1.93–23.56, P = 0.003), adenocarcinoma histology (HR 3.32, 95% CI: 1.43–7.72, P = 0.005), and high NLR (HR 4.04, 95% CI: 1.87–8.73, P < 0.001) were independent predictors of worse PFS. Conclusion: High NLR independently predicts poor OS and PFS in women with cervical cancer with HIV.
- 14 April 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 175 (1) , 300-309
Neutrophil‐to‐lymphocyte ratio as a prognostic marker for survival outcomes in women with cervical cancer and HIV infection
Objective: This study aimed to determine the prognostic value of neutrophil‐to‐lymphocyte ratio (NLR) in women with cervical cancer infected with HIV. Methods: This retrospective cohort study included women with cervical cancer with HIV infection who underwent primary treatment at a tertiary hospital in southern Thailand between 2005 and 2019. Overall survival (OS) and progression‐free survival (PFS) were analyzed using the Kaplan–Meier method. Univariate and multivariate Cox regression analyses were used to determine the independent factors associated with OS and PFS. Results: Among 100 patients (median follow‐up time 37.63 months), the 5‐year OS and PFS rates were 64.5% (95% confidence interval [CI]: 55.0–75.6) and 58.2% (95% CI: 48.6–69.6), respectively. In the multivariate analysis, high NLR (hazard ratio [HR]: 3.53, 95% CI: 1.58–7.91, P = 0.002) and low equivalent total dose in 2 Gy fractions at point A (HR 2.14, 95% CI: 1.02–4.49, P = 0.045) were independent predictors of worse OS, while poor performance status (HR 6.73, 95% CI: 1.93–23.56, P = 0.003), adenocarcinoma histology (HR 3.32, 95% CI: 1.43–7.72, P = 0.005), and high NLR (HR 4.04, 95% CI: 1.87–8.73, P < 0.001) were independent predictors of worse PFS. Conclusion: High NLR independently predicts poor OS and PFS in women with cervical cancer with HIV.